Show
Sort by
-
Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis
-
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFN gamma-based cancer therapy in mice
-
Description and mapping of the resistance of DBA/2 mice to TNF-induced lethal shock
-
The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy
-
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis
-
Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality
-
Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes
-
Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?
-
MMP-2 and MMP-9 synergize in promoting choroidal neovascularization
-
Serine proteases of the fibrinolysis pathway are not involved in lethal hepatitis and fibrinogen breakdown induced by tumor necrosis factor
-
Hyporesponsiveness of SPRET/Ei mice to lethal shock induced by tumor necrosis factor and implications for a TNF-based antitumor therapy
(2002) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 99(14). p.9340-9345 -
HSP70 protects against TNF-induced lethal inflammatory shock.
-
Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor.
-
Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor.
-
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.